Firivumab (CT-P22; CT120) is a human IgG1 monoclonal antibody targeting influenza A virus hemagglutinin (Anti-IAV HA). This antibody demonstrates a broad neutralizing capacity against multiple subtypes including H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2, and H12N7. In vivo studies have confirmed Firivumab's protective efficacy against the H1N1 virus in murine models, highlighting its potential for therapeutic applications in influenza A virus infections.
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal antibody targeting influenza A virus hemagglutinin (Anti-IAV HA). This antibody demonstrates a broad neutralizing capacity against multiple subtypes including H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2, and H12N7. In vivo studies have confirmed Firivumab's protective efficacy against the H1N1 virus in murine models, highlighting its potential for therapeutic applications in influenza A virus infections.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
